Which of the following drugs should not be used in setting of severe hypeension in elderly on empirical basis?
## Core Concept
The question tests the understanding of managing severe hypertension, particularly in the elderly population. The management of hypertension, especially when severe, requires careful consideration of the patient's age, comorbidities, and potential side effects of antihypertensive drugs.
## Why the Correct Answer is Right
The correct approach to managing severe hypertension involves using drugs that have a predictable effect and a favorable safety profile, especially in the elderly. Drugs that cause significant vasodilation or decrease blood pressure rapidly can lead to end-organ hypoperfusion. Among the options provided, **nifedipine**, a calcium channel blocker, particularly the immediate-release formulation, is known for its rapid onset of action and potential to cause severe hypotension. This makes it risky for use in severe hypertension, especially in the elderly, without close monitoring.
## Why Each Wrong Option is Incorrect
- **Option A:** Not specified, but assuming it's an ACE inhibitor or another class of antihypertensive that doesn't cause rapid vasodilation.
- **Option B:** Similarly, not specified, but if it's a drug like labetalol or another beta-blocker, these can be used cautiously in hypertension.
- **Option C:** Without specifics, if this option represents drugs commonly used for severe hypertension like nitroprusside, it would be used with caution in a monitored setting.
## Clinical Pearl / High-Yield Fact
A key point to remember is that **nifedipine**, especially the immediate-release form, should be avoided in the acute management of severe hypertension due to the risk of precipitous drops in blood pressure. For rapid blood pressure control, drugs like **labetalol**, **esmolol**, or **nitroprusside** are often preferred in an inpatient setting where close monitoring is possible.
## Correct Answer: D. Nifedipine.